Table 2.
System performance and expert evaluation on the test set
| Unstable angina/non-ST-segment elevation myocardial infarction | True positive | False positive | False negative | True negative | Total | Overall accuracy | κ Value | Sensitivity | Specificity | Positive predictive value | Negative predictive value | Attainment rate by system | Attainment rate by gold standards | |
| Measure 1 | Early invasive approach by coronary angioplasty | 264 | 33 | 78 | 252 | 627 | 0.823 | 0.65 | 0.77 | 0.88 | 0.889 | 0.76 | 0.48 | 0.55 |
| Measure 3 | ACE inhibitors/angiotensin receptor blockers before discharge (poor left ventricular ejection fraction) | 48 | 1 | 2 | 22 | 73 | 0.958 | 0.91 | 0.96 | 0.96 | 0.980 | 0.92 | 0.67 | 0.68 |
| Measure 4 | Aspirin before discharge | 474 | 2 | 5 | 24 | 505 | 0.986 | 0.87 | 0.99 | 0.92 | 0.996 | 0.83 | 0.94 | 0.95 |
| Measure 5 | β-blockers before discharge | 296 | 1 | 6 | 185 | 488 | 0.986 | 0.97 | 0.98 | 0.99 | 0.997 | 0.97 | 0.61 | 0.62 |
| Measure 6 | Statin before discharge | 167 | 0 | 7 | 340 | 514 | 0.986 | 0.97 | 0.96 | 1.00 | 1.000 | 0.98 | 0.32 | 0.34 |
Measures 7 and 8 are reported in the text.